top of page

ABOUT

LMH Strategic Solutions, LLC is a Washington, D.C. based public and government affairs firm that helps clients navigate complex policy and business challenges. Created in 2024 by founder Alanna Temme, LMH partners with health care companies, trade associations, and innovators to advance legislative priorities, strengthen relationships, and achieve strategic goals.

​

Since its founding in 2024, LMH has grown to represent clients across the health care and life sciences sectors, offering a concierge approach grounded in experience, strategy, and results. The firms name - LMH, honoring Alanna's three children, Lily, Maddie, and Henry - reflects its commitment to breaking barriers and driving meaningful impact.​​

IMG_3918_edited.jpg

OUR TEAM

The LMH team brings experience from Capitol Hill, Fortune 500 companies, and the life sciences industry. Together, we combine policy expertise, strategic insight, and a results-driven mindset to help clients meet their advocacy and business objectives.

Alanna Temme

Founder

Alanna Temme is the founder of LMH Strategic Solutions and brings nearly 20 years of senior leadership experience in the life sciences industry, specialty providers, and Capitol Hill. She specializes in legislative strategy, public policy advocacy, coalition management, and corporate strategy, helping clients successfully navigate complex policy and business challenges.

 

Alanna previously served as a health care policy advisor to a senior member of the House Ways and Means Committee, where she developed a broad bipartisan network. She has deep experience working with trade associations and coordinating strategic communications with policymakers and grassroots stakeholders.

 

In addition, Alanna serves as a board member and President of the Midsized Biotech Alliance of America.

Sophie Trainor Khanahmadi

Vice President

Sophie has spent 16 years shaping congressional policy, most recently serving as Deputy Staff Director of the House Energy & Commerce Committee under Chairman Brett Guthrie (R-KY). Before that, she spent several years as his Chief of Staff, driving his agenda, leading the team, and delivering real results on major policy priorities.

Sophie brings her deep expertise, strong relationships across the Hill, and proven track record to LMH.

WEB - 2026-04 - Sophie _17 - 07.jpg

Sonia Goh

Director of Government Affairs & Health Policy

Sonia serves as Director of Government Affairs at LMH Strategic Solutions, where she leverages deep expertise in federal health policy and program compliance to support a diverse health care portfolio, with a focus on legislative advocacy. She specializes in cultivating strategic relationships with Capitol Hill staff, enabling LMH to deliver timely policy insights, anticipate legislative activity, and effectively advance client priorities.

 

Prior to joining LMH, Sonia worked as a CMS Auditor at Ernst & Young, gaining technical expertise in federal health programs and compliance, and previously served as a Legislative Intern monitoring communications from federal health agencies. Her combined technical and relationship-driven background allows her to support clients with a well-rounded understanding of the political and regulatory landscape.

WEB - 2026-04 - Sonia _71 - 05.jpg

Max Walter

Director of Government Affairs & Health Policy

Max serves as the Director of Government Affairs & Health Policy at LMH Strategic Solutions. Bridging the gap between scientific innovation and public policy, Max supports a portfolio of biotechnology and pharmaceutical clients with a focus on market access and regulatory affairs. His particular niche lies in translating complex clinical data into credible policy arguments, allowing clients to effectively communicate the value of novel technologies to Capitol Hill.

​

Prior to joining LMH, Max worked as a Research Engineer and holds an M.S. in Bioengineering from the University of Washington. This combination of technical expertise and policy acumen ensures clients are supported by a deep understanding of both the science behind their innovations and the regulatory landscape they must navigate.

WEB - 2026-04 - Max _36 - 03.jpg
bottom of page